The many faces of traf molecules in immune regulation

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3483-3485

  Bishop, Gail A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ANTIBODY AFFINITY; ANTIBODY RESPONSE; B LYMPHOCYTE ACTIVATION; BINDING SITE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL SURVIVAL; CELLULAR IMMUNITY; EDITORIAL; HUMAN; HUMORAL IMMUNITY; HYPER IGM SYNDROME; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; T LYMPHOCYTE ACTIVATION;

ALLERGY AND IMMUNOLOGY; ANIMALS; HISTORY, 20TH CENTURY; HUMANS; IMMUNOMODULATION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84885098977     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1390048     Document Type: Editorial

References (47)

1. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature 314:537-539.
2. Bishop, G. A., and G. Haughton. 1986. Induced differentiation of a transformed clone of Ly-11 B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci. USA 83:7410-7414.
3. Bishop, G. A., and J. A. Frelinger. 1989. Haplotype-specific differences in signaling by transfected class II molecules to a Ly-11 B-cell clone. Proc. Natl. Acad. Sci. USA 86:5933-5937.
4. Bishop, G. A., M. S. McMillan, G. Haughton, and J. A. Frelinger. 1988. Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes. Immunogenetics 28:184-192.
5. Bishop, G. A. 1991. Requirements of class II-mediated B cell differentiation for class II cross-linking and cyclic AMP. J. Immunol. 147:1107-1114.
6. Harton, J. A., and G. A. Bishop. 1993. Length and sequence requirements of the cytoplasmic domain of the A b molecule for class II-mediated B cell signaling. J. Immunol. 151:5282-5289.
7. Harton, J. A., W. Litaker, J. A. Frelinger, and G. A. Bishop. 1991. Structure function analysis of the H-2 Abp gene. Immunogenetics 34:358-365.
8. Harton, J. A., A. E. Van Hagen, and G. A. Bishop. 1995. The cytoplasmic and transmembrane domains of MHC class II b chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 3:349-358.
9. Scholl, P. R., and R. S. Geha. 1994. MHC class II signaling in B-cell activation. Immunol. Today 15:418-422.
10. Callard, R. E., R. J. Armitage, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559-564.
11. Banchereau, J., F. Bazan, D. Blanchard, F. Brière, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994.. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
12. Laman, J. D., E. Claassen, and R. J. Noelle. 1996. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:59-108.
13. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415-419.
14. Stout, R. D., and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today 17:487-492.
15. Van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
16. Baccam, M., and G. A. Bishop. 1999. Membrane-bound CD154, but not anti-CD40 mAbs, induces NF-κB independent B cell IL-6 production. Eur. J. Immunol. 29:3855-3866.
17. Hostager, B. S., Y. Hsing, D. E. Harms, and G. A. Bishop. 1996. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 157:1047-1053.
18. Hsing, Y., B. S. Hostager, and G. A. Bishop. 1997. Characterization of CD40 signaling determinants regulating nuclear factor-k B activation in B lymphocytes. J. Immunol. 159:4898-4906.
19. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494-1498.
20. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996.. Identification of TRAF6, a novel TRAF protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745-28748.
21. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J.-I. Inoue. 1996. TRAF5, a novel TNF-R-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93:9437-9442.
22. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-k B by TNF receptor 2 and CD40. Science 269:1424-1427.
23. Busch, L. K., and G. A. Bishop. 1999. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocytes. J. Immunol. 162:2555-2561.
24. Graham, J. P., K. M. Arcipowski, and G. A. Bishop. 2010. Differential B lymphocyte regulation by CD40 and its viral mimic, LMP1. Immunol. Rev. 237:226-248.
25. Lyons, S. F., and D. N. Liebowitz. 1998. The roles of human viruses in the pathogenesis of lymphoma. Semin. Oncol. 25:461-475.
26. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
27. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell. Biol. 16:7098-7108.
28. Shirakata, M., K. Imadome, K. Okazaki, and K. Hirai. 2001. Activation of TRAF5 and TRAF6 signal cascades negatively regulates the latent replication origin of EBV through p38 mitogen-activated protein kinase. J. Virol. 75:5059-5068.
29. Lomaga, M. A., W. C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. 1999.. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.
30. Xu, Y., G. Cheng, and D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5:407-415.
31. Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al. 1997.. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-725.
32. Hostager, B. S., S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop. 2003. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278:45382-45390.
33. Arcipowski, K. M., and G. A. Bishop. 2012. TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1. J. Immunol. 189:5165-5170.
34. Arcipowski, K. M., L. L. Stunz, J. P. Graham, Z. J. Kraus, T. J. Vanden Bush, and G. A. Bishop. 2011. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1). J. Biol. Chem. 286:9948-9955.
35. Graham, J. P., C. R. Moore, and G. A. Bishop. 2009. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1. J. Immunol. 183:2966-2973.
36. Kraus, Z. J., H. Nakano, and G. A. Bishop. 2009. TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40. Proc. Natl. Acad. Sci. USA 106:17140-17145.
37. Xie, P., B. S. Hostager, and G. A. Bishop. 2004. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp. Med. 199:661-671.
38. Xie, P., B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop. 2006. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J. Immunol. 176:5388-5400.
39. Haxhinasto, S. A., B. S. Hostager, and G. A. Bishop. 2002. Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. J. Immunol. 169:1145-1149.
40. Hostager, B. S., and G. A. Bishop. 1999. Cutting Edge: Contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation. J. Immunol. 162:6307-6311.
41. Xie, P., and G. A. Bishop. 2004. Roles of TRAF3 in signaling to B lymphocytes by CTAR regions 1 and 2 of the EBV-encoded oncoprotein LMP1. J. Immunol. 173:5546-5555.
42. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317-1318.
43. Xie, P., L. L. Stunz, K. D. Larison, B. Yang, and G. A. Bishop. 2007. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27:253-267.
44. Gardam, S., F. Sierro, A. Basten, F. Mackay, and R. Brink. 2008. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28:391-401.
45. Xie, P., J. S. Poovassery, L. L. Stunz, S. M. Smith, M. L. Schultz, L. E. Carlin, and G. A. Bishop. 2011. Enhanced TLR responses of TRAF3-deficient B lymphocytes. J. Leukoc. Biol. 90:1149-1157.
46. Xie, P., Z. J. Kraus, L. L. Stunz, Y. Liu, and G. A. Bishop. 2011. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 186:143-155.
47. Yi, Z., L. L. Stunz, and G. A. Bishop. 2013. TNF receptor-associated factor 3 plays a key role in the development and function of iNKT cells. J. Exp. Med. 210:1079-1086.